Dr Mohamed Elnaggar chaired the session
Health Innovation North West Coast has joined forces with charity HEART UK and Lancashire and South Cumbria Integrated Care Board to help improve the treatment of cholesterol in the region.
The Tackling Cholesterol Together Roadshow in Preston was part of a series of events staged by HEART UK, the UK’s only cholesterol charity, and drew dozens of clinicians from across the primary and secondary sectors.
They were able to share best practice and discuss challenges in areas such as assessing risk, managing primary and secondary prevention, identifying familial hypercholesteroleamia, the interface between primary and secondary care, myth-busting about statins and lipid-lowering therapies.
The event was chaired by Dr Mohamed Elnaggar, Health Innovation North West Coast’s Clinical Lipid Lead for Lancashire and South Cumbria.
Dr Elnaggar said: “Cardiovascular disease is a significant cause of death and disability and is a particular concern in our part of the country.
“The roadshow was an excellent opportunity to bring people together to share ideas and make sure the very latest thinking and best practice reaches every part of the region.”
The roadshow series is a national educational initiative aligned with the NHS Long Term Plan and Cardiovascular Disease Prevention Programme. The Plan’s ambition is to prevent over 150,000 heart attacks, strokes and dementia cases by 2029.
News and blogs >
Hospitals trial test to speed up diagnosis of children with infections Read more
An innovative 15-minute blood test which can fast-track the diagnosis of children with potentially life-threatening conditions is being trialled by the NHS in Liverpool this winter.
Partnerships pave the way to better outcomes Read more
The incoming chief executive of NHS Lancashire and South Cumbria has urged health and care leaders to strengthen cross-sector partnerships to help the region tackle its most intractable challenges.
Novartis partnership opportunity for “best access to the best care” Read more
We convened the Novartis UK senior leadership team and the Cheshire and Merseyside life sciences system to set ambitions and agree priorities for an exciting new partnership.
Funding boost for respiratory care Read more
Patients in Liverpool will benefit from the improved treatment of asthma and chronic obstructive pulmonary disorder (COPD) after the region won funding for a package of innovative projects.